CHAS Health

chas.org

The mission of CHAS Health is to improve the overall health of the communities we serve by expanding access to quality health and wellness services. As a community health center, CHAS Health provides high-quality medical, dental, behavioral health and pharmacy care to people of all ages, regardless of insurance status. When patients walk through the doors of a CHAS Health clinic, they step inside their health care home, a place where most needs can be met under one roof. With twelve clinics throughout the Inland Northwest, and more on the way, CHAS Health serves a critical need in the community and we are constantly looking for talented and dedicated individuals to join our team. If you're looking to make a difference in the lives of people in your community, CHAS Health could be be right for you.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

AQUESTIVE THERAPEUTICS RECEIVES FDA TENTATIVE APPROVAL FOR LIBERVANT™ (DIAZEPAM) BUCCAL FILM

Aquestive Therapeutics, Inc. | August 31, 2022

news image

Aquestive Therapeutics, Inc. a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, announced today that the U.S. Food & Drug Administration has granted tentative approval for Libervant™ Buccal Film for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity that are distinct from a patient’s usual seizure pattern in patients with epileps...

Read More

Pharma Tech

WCG ANNOUNCES PARTNERSHIP WITH MINT MEDICAL TO SUPPORT IMAGING IN ONCOLOGY CLINICAL TRIALS

PRNewswire | June 29, 2023

news image

WCG, one of the world's leading providers of solutions that measurably improve the quality, efficiency, and safety of clinical research, recently announced a partnership with Mint Medical to leverage its mint Lesion™ radiology platform for oncology trials. The mint Lesion™ software is used for standardized and computer-assisted review of medical imaging according to defined protocols, guidelines, and workflows. Compliant and highly configurable, mint Lesion&trade...

Read More

Pharma Tech

BEIGENE-NOVARTIS PD-1 DEAL; SINOVAC VACCINE; CELLTRION ANTIBODY COVID-19 DATA

Novartis | January 19, 2021

news image

Novartis plunked down up to $2.2 billion for BeiGene's China-approved PD-1 drug tislelizumab to complement its own checkpoint inhibitor. Hear what BeiGene CEO John Oyler has to say about tislelizumab's position in and outside China. Sinovac's COVID-19 vaccine reported confusing data from Brazil, raising doubt about its true efficacy. Celltron's anti-SARS-CoV-2 antibody improved patients' outcomes in a phase 2/3 trial. And more. Novartis paid $650 million upfron...

Read More

Pharmacy Market

WUXI BIOLOGICS LAUNCHES FIRST COMMERCIAL DRUG PRODUCT FACILITY FOR PRE-FILLED SYRINGES

WuXi Biologics | June 06, 2022

news image

WuXi Biologics a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi Biologics. The DP5 facility features an advanced isolator filling line for continuous and steady filling services, which offers multiple volume delivery options for pre-filled syringes including 1 mL Long, 1 mL, 2.25 mL and 3 mL. The m...

Read More
news image

Business Insights

AQUESTIVE THERAPEUTICS RECEIVES FDA TENTATIVE APPROVAL FOR LIBERVANT™ (DIAZEPAM) BUCCAL FILM

Aquestive Therapeutics, Inc. | August 31, 2022

Aquestive Therapeutics, Inc. a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, announced today that the U.S. Food & Drug Administration has granted tentative approval for Libervant™ Buccal Film for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity that are distinct from a patient’s usual seizure pattern in patients with epileps...

Read More
news image

Pharma Tech

WCG ANNOUNCES PARTNERSHIP WITH MINT MEDICAL TO SUPPORT IMAGING IN ONCOLOGY CLINICAL TRIALS

PRNewswire | June 29, 2023

WCG, one of the world's leading providers of solutions that measurably improve the quality, efficiency, and safety of clinical research, recently announced a partnership with Mint Medical to leverage its mint Lesion™ radiology platform for oncology trials. The mint Lesion™ software is used for standardized and computer-assisted review of medical imaging according to defined protocols, guidelines, and workflows. Compliant and highly configurable, mint Lesion&trade...

Read More
news image

Pharma Tech

BEIGENE-NOVARTIS PD-1 DEAL; SINOVAC VACCINE; CELLTRION ANTIBODY COVID-19 DATA

Novartis | January 19, 2021

Novartis plunked down up to $2.2 billion for BeiGene's China-approved PD-1 drug tislelizumab to complement its own checkpoint inhibitor. Hear what BeiGene CEO John Oyler has to say about tislelizumab's position in and outside China. Sinovac's COVID-19 vaccine reported confusing data from Brazil, raising doubt about its true efficacy. Celltron's anti-SARS-CoV-2 antibody improved patients' outcomes in a phase 2/3 trial. And more. Novartis paid $650 million upfron...

Read More
news image

Pharmacy Market

WUXI BIOLOGICS LAUNCHES FIRST COMMERCIAL DRUG PRODUCT FACILITY FOR PRE-FILLED SYRINGES

WuXi Biologics | June 06, 2022

WuXi Biologics a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi Biologics. The DP5 facility features an advanced isolator filling line for continuous and steady filling services, which offers multiple volume delivery options for pre-filled syringes including 1 mL Long, 1 mL, 2.25 mL and 3 mL. The m...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us